AGP Executive Report
Last update: 12 hours agoHealth Research: Preliminary research links cannabis use—smoked or edible—with higher cardiovascular risk, particularly stroke, raising questions for patient counseling. Regulation: The American Medical Association is urging science-based safety standards for cannabis and other botanical products, while calling for a special federal pathway to support research into marijuana’s medical potential. Medical Access: The DEA registered more than 900 medical cannabis dispensaries, but none in states with adult-use markets; registration could bring tax relief and access to traditional banking. Industry: Tilray plans to consolidate Canadian cultivation and pre-roll production, targeting about US$10 million in annual savings and raising the lower end of its 2027 earnings outlook. Global Policy: A Nepal court ruling could open the door to legal cannabis cultivation after five decades, while a U.S. congressional bill would impose new tariffs and testing requirements on hemp imports.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.